Australia's notifiable diseases status, 2001: Annual report of the National Notifiable Diseases Surveillance System

The Australia’s notifiable diseases status 2000 report provides data and an analysis of communicable disease incidence in Australia during 2000. This section of the annual report contains a report on antibiotic resistance in Australia. The full report can be viewed in 25 HTML documents and is also available in PDF format. The 2001 annual report was published in Communicable Diseases Intelligence Vol 27, No 1, March 2003.

Page last updated: 08 April 2003

A print friendly PDF version is available from this Communicable Diseases Intelligence issue's table of contents.

Other communicable disease surveillance

Antibiotic resistance in Australia

Since the release of The Commonwealth Government Response to the Report of the Joint Expert Technical Advisory Group on Antibiotic Resistance (JETACAR) in October 2000, the government has continued its work toward the development of a national antibiotic resistance management program.113 Two committees were established to further this aim:
  • The Expert Advisory Group for Antimicrobial Resistance (EAGAR), was set up in April 2001 under the auspices of the National Health and Medical Research Council, to provide continuing advice on antibiotic resistance and related matters; and
  • The Commonwealth Interdepartmental JETACAR Implementation Group was established in November 2000, to oversee and coordinate the continuing government response to JETACAR, to respond to the policy advice received from EAGAR and to seek funding for implementation purposes.
During 2001, EAGAR developed and commenced the use of a protocol to assess the risk of antibiotic resistance developing in new and existing antibiotics.

Activities undertaken by the Commonwealth Interdepartmental JETACAR Implementation Group and its member agencies in 2001 include:
  • an informal consultation meeting in March, The Monitoring of the Distribution of Antibiotics for Veterinary and Human Use in Australia; and
  • the release in April of the draft report, National surveillance of healthcare associated infection in Australia, for consultation.
Other important activities included:
  • the workshop on Antibiotic Resistance Surveillance(4 May);
  • the National Summit on Antibiotic Resistance (30 and 31 May);
  • a nationwide consultation toward development of a National Antibiotic Resistance Surveillance System for Antibiotic Resistance Management (July-September); and
  • the initiation of the EAGAR website -(This web site was available at at the time of publication.)
Progress reports on implementation of the Government Response are available on the implementing JETACAR website - (This web site was available at at the time of publication.)

Through the National Summit on Antibiotic Resistance, representatives from governments, health, agricultural, industry and consumer groups identified priorities for action. In particular, the need for the development of a national system of surveillance for antibiotics was recognised to measure the prevalence of antibiotic resistance. Further needs were also identified including:
  • improved education and awareness, leading to more appropriate use of antibiotics;
  • clearer research focuses, and better communication and regulation;
  • more effective linkages between corporate and peak organisational bodies; and
  • reduced incidence of health care-associated infections in Australia.

This article was published in Communicable Diseases Intelligence Volume 27, No 1, March 2003.

Communicable Diseases Intelligence subscriptions

Sign-up to email updates: Subscribe Now